$55.02 +0.01 (%) Alkermes PLC - NASDAQ

Nov. 28, 2014 | 01:00 PM

Partner Headlines

  1. Top 4 Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga | Nov. 11, 2014 | 04:15AM EST
  2. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  3. Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Spectrum Oral Antipsychotic

    Benzinga | Sep. 3, 2014 | 07:04AM EST
  4. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | Aug. 25, 2014 | 07:28AM EST
  5. Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc

    Benzinga | Aug. 14, 2014 | 09:40AM EST
  6. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga | Apr. 30, 2014 | 07:32AM EST
  7. Alkermes' drug passes trial

    IBD | Apr. 8, 2014 | 18:54PM EST
  8. Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

    Benzinga | Apr. 8, 2014 | 16:54PM EST
  9. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD | Apr. 8, 2014 | 16:21PM EST
  10. Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength

    Benzinga | Apr. 8, 2014 | 15:46PM EST
  11. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast

    Benzinga | Apr. 8, 2014 | 13:22PM EST
  12. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD | Apr. 8, 2014 | 12:12PM EST
  13. Benzinga's Volume Movers

    Benzinga | Apr. 8, 2014 | 10:55AM EST
  14. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook

    Benzinga | Apr. 8, 2014 | 10:29AM EST
  15. Morning Market Movers

    Benzinga | Apr. 8, 2014 | 09:38AM EST
  16. Alkermes Announces Positive Topline Results From Pivotal Phase 3 Study of Aripiprazole Lauroxil

    Benzinga | Apr. 8, 2014 | 07:01AM EST
  17. Benzinga's Top Initiations

    Benzinga | Apr. 2, 2014 | 07:49AM EST
  18. Nasdaq Back Above Water; Green Plains Jumps

    IBD | Mar. 21, 2014 | 11:54AM EST
  19. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD | Feb. 20, 2014 | 08:02AM EST
  20. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD | Feb. 19, 2014 | 16:21PM EST
  21. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD | Feb. 19, 2014 | 14:53PM EST
  22. Stocks End Short Week With Big Losses

    IBD | Jan. 24, 2014 | 17:03PM EST
  23. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga | Jan. 8, 2014 | 07:02AM EST
  24. Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug for MS

    Benzinga | Jan. 6, 2014 | 07:04AM EST
  25. Ireland Home To Several Fast Growing Health Care Names

    IBD | Dec. 24, 2013 | 17:02PM EST
  26. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ACNP Meeting

    Benzinga | Dec. 9, 2013 | 07:13AM EST
  27. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga | Oct. 17, 2013 | 09:26AM EST
  28. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development Program

    Benzinga | Oct. 9, 2013 | 07:05AM EST
  29. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga | Sep. 20, 2013 | 04:16AM EST
  30. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD | Sep. 19, 2013 | 13:58PM EST
  31. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD | Aug. 5, 2013 | 18:01PM EST
  32. Stocks End Mixed In Light Trade; Green Mountain Spurts Ahead

    IBD | Aug. 5, 2013 | 16:21PM EST
  33. Stocks Down Modestly; Alkermes Ramps Up

    IBD | Aug. 5, 2013 | 11:53AM EST
  34. Alkermes

    IBD | Jul. 25, 2013 | 18:52PM EST
  35. Stocks Up, Google At High; Dow Takes Out 14,000

    IBD | Feb. 6, 2013 | 05:10AM EST
  36. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD | Feb. 1, 2013 | 11:20AM EST
  37. Alkermes

    IBD | Jan. 31, 2013 | 11:48AM EST
  38. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    IBD | Jan. 30, 2013 | 08:16AM EST
  39. Alkermes Trades Tightly, Holds In Buying Range

    IBD | Jan. 17, 2013 | 07:48AM EST
  40. UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking For Better Entry

    Benzinga | Jan. 17, 2013 | 06:12AM EST
  41. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD | Jan. 15, 2013 | 01:05AM EST
  42. Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates For The Next Quarter

    Benzinga | Jan. 13, 2013 | 19:30PM EST
  43. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    IBD | Jan. 9, 2013 | 05:02AM EST
  44. Alkermes In Buy Area After Breakout In Strong Volume

    IBD | Jan. 8, 2013 | 11:08AM EST
  45. Stocks Pare Early Losses, End With Modest Declines

    IBD | Jan. 7, 2013 | 09:14AM EST
  46. Alkermes Announces Notice of Allowance of USPTO Application for Aripiprazole Lauroxil

    Benzinga | Jan. 3, 2013 | 00:18AM EST
  47. Alkermes Announces Positive Results from Phase 1 Study of ALKS 3831

    Benzinga | Jan. 3, 2013 | 00:14AM EST
  48. Biotech Alkermes Sketches Imperfect Cup With Handle

    IBD | Dec. 13, 2012 | 10:10AM EST
  49. Alkermes' Acquisition Proves To Be Game-Changer

    IBD | Nov. 30, 2012 | 10:00AM EST
  50. Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences

    Benzinga | Nov. 7, 2012 | 09:02AM EST
Trading Center